港股不行了?今天这家新药上市又是大跌30%

动脉网
Dec 23, 2025

2025年12月23日,湖北武汉的翰思艾泰生物科技(武汉)股份有限公司在港交所上市,大跌30%。本次发行1832.1万股,发行价32港元/股,规模约5.9亿港元(约合7500万美元)。公司有核心产品HX009(PD-1/SIRPα双功能抗体融合蛋白)、两款主要产品HX044及HX301,还有7项临床前阶段候选药物。其定位是提供新一代肿瘤免疫治疗、一流ADC分子及新型自身免疫治疗。2023年、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10